Comment on “Long-term survival of patients who received atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma”

Journal of the Formosan Medical Association 2026 Open access

Read full text

Authors: Yanting Liu, Shentao Wang, Kai Wang, Pengnuo Sui, Jing Yu

DOI: 10.1016/j.jfma.2026.01.004

Cited by: 0

References: 3

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies

References 3